Bausch Health Cos Net Common Equity Issued/Repurchased 2010-2024 | BHC
Bausch Health Cos net common equity issued/repurchased from 2010 to 2024. Net common equity issued/repurchased can be defined as the net dollar amount of transactions to issue and repurchase common stock.
Bausch Health Cos Annual Net Common Equity Issued/Repurchased
(Millions of US $) |
| 2024 |
$ |
| 2023 |
$ |
| 2022 |
$675 |
| 2021 |
$ |
| 2020 |
$ |
| 2019 |
$ |
| 2018 |
$ |
| 2017 |
$ |
| 2016 |
$33 |
| 2015 |
$1,391 |
| 2014 |
$17 |
| 2013 |
$2,262 |
| 2012 |
$-258 |
| 2011 |
$-598 |
| 2010 |
$-2 |
| 2009 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.381B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
